ABZYME RESEARCH FOUNDATION Co Jamie Drake Design
Nonprofit profile at a glance
- EIN
- 273438658
- IRS 990-EZ coverage
- 2017–2025
- Forms available
- Form 990-EZ 2025, Form 990-T 2025
- Location
- New York, NY, USA
- Phone
- 3479673734
- Rating confidence
- Limited
- Sector
- AIDS Research
Reported finances
- Revenue
- $164,001
- Expenses
- $142,754
- Assets
- $357,202
- Liabilities
- $657
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
8 people listed
People named in this filing
- ZACHARY BARNETT (Director)
- VALERIE KERR (Director)
- BETH MILLER SAKS (Director)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The successful completion of the pre-investigational new drug meeting with the fda as wellas the initiation of a scale-up of the manufacturing of the vaccine compound.
What it reported doing in 2025
Advance the development of abzyme technology in the hopes of producing the world's first effective HIV vaccine and improved treatment for over 36 million HIV positive people worldwide
Operating model
- Revenue model
- Cannot be determined from the filing. The filing does not provide enough consistent revenue detail to tell how this nonprofit funds its work.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: NotEnoughData
- Transparency & Controls: 82
- Sustainability: 66
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: 13%; rating input score 61; 61st percentile among comparable filings
- Total-asset coverage ratio: 2.5; rating input score 85; 85th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 45; 45th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings
Growth
- Program expense growth: -121.8% per year; rating input score 0; 1st percentile among comparable filings
- Revenue growth: -10.8% per year; rating input score 0; 4th percentile among comparable filings
- Asset growth: -1.1% per year; rating input score 0; 23rd percentile among comparable filings
Details
- Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment
- Leadership: top reported pay $0 · 8 people listed
- Consistency: 6 of 6 current checks pass
- Schedules: 2 filed schedules
- Filing history: 7 filing years from 2017 to 2025
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Growth: Asset growth scored 0/100.
- Moderate — Sustainability: Liabilities to assets ratio scored 45/100.